Korro Bio, Inc.KRRONASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank75
3Y CAGR+14.9%
5Y CAGR+7.3%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+14.9%/yr
vs +34.0%/yr prior
5Y CAGR
+7.3%/yr
Recent acceleration
Acceleration
-19.1pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$89.45M-5.0%
2024$94.18M+11.4%
2023$84.53M+43.3%
2022$59.00M-37.4%
2021$94.26M+49.7%
2020$62.95M+91.9%
2019$32.81M+79.4%
2018$18.29M+15.9%
2017$15.78M-